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As a result of the age-related changes, more elders live in long-term care fa-
cilities (LTCFs). Due to their susceptibility, infections and excess use of antimicro-
bials are common. The aim was to estimate the burden of infections and antimicro-
bial use in Hungarian LTCFs in order to increase the attention given to the prevention. 
European-wide point prevalence survey was conducted between April and May 
2013. For each resident who had a signs and symptoms of an infection and/or treated 
with an antibacterial for systemic use a resident questionnaire was completed. De-
scriptive statistics were used to present the data. In total, 91 LTCFs with 11,823 resi-
dents were selected in this survey. The 252 residents had a sign/symptom of an infec-
tion (2.1%) and 156 received antimicrobial (1.3%). Skin and soft tissues (36.5%) was 
the most frequent infection. However, antimicrobials were mostly prescribed for 
respiratory tract infections (40.4%). The most common therapeutic antimicrobial 
agent (97.5%) belonged to the quinolone antibacterials (34.2%). Our results empha-
sise the need for targeted improvement of antimicrobial use including: reducing the 
use of quinolone antibacterials in order to prevent the spread of Clostridium diffi cile 
and other antimicrobial resistant microorganisms among institutionalized residents.
Keywords: elderly, long-term care facilities, infections, antimicrobial use, 
Hungary
Introduction
The number of people aged 65 years and over is increasing worldwide. 
In Hungary, the number of elderly people has increased from 1,372,661 in 1960 
to more than 2,364,420 to date and is growth with 0.2% annually [1]. As a result 
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of the age-related changes (e.g. impaired mobility, incontinence and disorienta-
tion) and changed healthcare system (e.g. early hospital discharge), more and 
more elders (39,847 in 2000 and 51,736 in 2012) live in long-term care facilities 
(LTCFs), corresponding to approximately 5% of the total Hungarian elderly pop-
ulation [1].
Residents of LTCFs are at high risk at infections due to their increased 
susceptibility (e.g. immunosenesence) and institutional factors (e.g. low priority 
of infection prevention and control measures) [2]. Recent reports with different 
methodologies indicated that the prevalence of infections is between 2.6% and 
11.3% [3–4]. Because of infections, residents are often treated with antimicrobial 
agents. The most important adverse outcome of the excess use of antimicrobial 
agents is the emergence of multidrug resistant microorganisms, such as methicil-
lin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococ-
cus spp. (VRE) [5–9].
Due to the lack of EU-wide cross-country comparable data on infections 
and antimicrobial use in LTCFs, the European Centre for Disease Prevention and 
Control (ECDC) funded the HALT project (Healthcare Associated Infections in 
Long-Term Care Facilities) in 2008. The aims were to estimate the burden of in-
fections and antibiotic use and to collect data on infection control practices in 
order to increase the attention given to the prevention in LTCFs.
After a pilot survey in 2009 (including 4 Hungarian LTCFs), a fi rst EU-
wide point prevalence survey was performed between May and September 2010, 
including 25 countries with 722 LTCFs (including 42 Hungarian LTCFs). Based 
on the experience of the fi rst HALT, the methodology was slightly improved and 
a repeated survey (HALT-2) was set up in 2013 including 19 countries with 1,181 
LTCFs [10–11].
This article presents the Hungarian results from the HALT-2 project, fo-
cusing on the burden of infections and antimicrobial use in participating LTCFs.
Methods
The European-wide repeated point-prevalence survey was conducted be-
tween April and May 2013 in 19 countries. Based on the protocol, the national 
coordinating institute (National Center for Epidemiology, NCE) organised the 
survey during the suggested period [11]. All LTCFs (e.g. general nursing care, 
residential care, psychiatric care, mixed care) with 50 beds and over (in total, 420 
LTCFs; 24% of all Hungarian LTCFs) were invited to participate voluntary in 
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this survey. Furthermore, it was recommended that the residents in these LTCFs 
need constant supervision and high-skilled nursing care, but do not need inva-
sive medical procedures (e.g. mechanical ventilation). Hospital long-term care 
wards, residential care (e.g. hotel without any kind of nursing care), sheltered care 
houses, day centers, home-based centers, resident fl at and protected living were 
excluded.
Within the participating LTCF, a resident was considered eligible for the 
survey if 1) she/he lived permanently in the LTCF, 2) had resided there for at least 
one day and 3) was present at 8 AM on the day of the survey. All eligible residents 
had to be included. Residents hospitalized on the survey day were excluded.
According to the protocol, data were collected at LTCF and resident level 
(for the latter, including infection and antimicrobial use data if any) on standard-
ised data collection forms (paper-based questionnaires). The LTCF questionnaire 
collected data on structural and functional characteristics of LTCF demographics 
(e.g. availability of qualifi ed nursing 24/24 h, total number of resident rooms), 
denominator data (e.g. predisposing factors of all eligible residents) and informa-
tion on infection control practices and antibiotic policy in the LTCF (e.g. number 
of infection control staff, presence of written protocols for prevention, total 
 annual consumption of alcohol hand rubs, use of restrictive list of antimicrobial 
agents).
For each eligible resident who showed a sign/symptom of an active infec-
tion and/or treated with an antibacterial agent on the day of the survey, a resident 
questionnaire was completed. This form also included questions on resident de-
mographics (e.g. age, sex, length of LTCF stay, admission to an acute care hospi-
tal in the last three months, surgery in the previous 30 days) and predisposing 
factors (e.g. presence of urinary catheter and/or vascular catheter, pressure sore 
or other wounds, urinary and/or faecal incontinence, disorientation in time 
and/or space, mobility). Infection data included the infection type correspond-
ing to one of the case defi nitions by applying decision algorithm. Data on anti-
microbial use included the antimicrobial name, administration route, type of 
treatment (prophylactic or therapeutic), indication for antimicrobial use (the site 
of diagnosis for treatment intention of an infection), place and person of pre-
scription, isolated microorganisms and selected antimicrobial resistance data 
(oxacillin-sensitive/resistant Staphylococcus aureus, glycopeptides-sensitive/re-
sistant Enterococcus species, 3rd generation cephalosporin and carbapenem-sen-
sitive/resistant Enterobacteriaceae, carbapenem-sensitive/resistant Pseudomonas 
aeruginosa, carbapenem-sensitive/resistant Acinetobacter baumannii).
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Case defi nitions for infections
The diagnosis of an infection in elderly residents can be diffi cult due to the 
atypical presentation of infections (e.g. pyrexia is not sensitive indicator of infec-
tion), decline in mental and/or cognitive functions (e.g. disorientation). In addi-
tion, diagnostic testing (e.g. radiology, microbiologic sampling) for detection and 
confi rmation of an infection is infrequent in LTCFs. Thus Centers for Disease 
Control and Prevention (CDC) case defi nitions for infections were used where 
these had been developed previously for LTCFs by McGeer et al. [12]. For the 
purposes of the protocol, an infection was defi ned as active on the day of the 
survey when signs and symptoms of the infection were present on the survey day 
or presented in the past and the resident were (still) received antimicrobial treat-
ment for that infection on the survey day.
Inclusion of antimicrobial agents
For antimicrobial use, the Anatomical Therapeutic Chemical (ATC) clas-
sifi cation system of the World Health Organization (WHO) Collaborating Centre 
for Drug Statistics Methodology was used [13]. All oral, rectal, intramuscular 
and intravenous treatment with antibacterials, antimycotics and antimycobacteri-
als for systemic use and antibiotic treatment by inhalation were included. Antivi-
rals for systemic use, antimicrobials for topical use and antiseptics were not in-
cluded.
Data collection and process
Participating LTCFs were asked to choose one single day in the course 
of the survey to collect all necessary data prospectively. The protocol recom-
mended that data from any single LTCF should all be collected on a single day. 
The total time frame for data collection for all wards of a large single LTCF was 
recommended not to exceed two consecutive days during the survey period.
Training
Because of it was important that surveyors record all signs and symp-
toms of infections on resident questionnaire to allow infection prevalence to be 
precisely estimated, training of LTCF staff was considered a priority throughout 
the preparation of the survey. In March 2013, six, one-day national training 
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courses were given by the NCE to explain the methodology and to instruct 
the data collection to the LTCF staff. Standardised training curriculum and mate-
rial was provided in English by the ECDC.
Data delivery
Collected data on paper forms were sent to the NCE by each LTCF and 
after data cleaning, these data were inputted into a stand-alone software pro-
gramme. An electronic copy of data from each LTCF was emailed securely to 
the ECDC EU-wide database without resident-identifying data.
Data analysis
We used descriptive statistics to summarise resident data – number (%) for 
categorical variables and median (interquartile range, IQR) for continuous vari-
ables. 95% confi dence intervals (CI) were calculated for the infection rate using 
with the Poisson distribution. The Mann–Whitney U-test was used to compare 
the differences between the prevalence with the infections, the three most fre-
quent types of infections and the antimicrobial use stratifi ed by type of demo-
graphics and predisposing factors. A P value of less than 0.05 was considered 
statistically signifi cant for all analysis. Statistical analyses were performed using 
EpiData version 3.1 (http://www.epidata.dk).
The prevalence of infections was reported as the percentage of residents 
with at least one infection over the total number of eligible residents. For infec-
tion types and isolated microorganism, relative frequencies were reported using 
the total number of infections or isolated microorganisms as the denominator.
The prevalence of antimicrobial use was reported as the percentage of 
 residents receiving at least one antimicrobial agent over the total number of 
eligible residents. For antimicrobials, relative frequencies among the total num-
ber of antimicrobials are given as the denominator.
Ethical consideration
Because of the survey did not entail any direct contact with patients, ethi-
cal approval was not important. Confi dentiality of data was assured by the use of 
a unique study number for each participating LTCFs and eligible residents allot-
ted by the NCE and/or by the surveyors.
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Results
A total of 91 LTCFs with 11,823 eligible residents were selected in this 
survey. The median size of the participating LTCFs was 102.5 beds and varied 
from 26 beds to 690 beds. Only 19.8% of LTCFs had single rooms for isolation.
The majority of all eligible residents were female (63.6%). The median age 
in the residents surveyed was 69 years (IQR, 58–97 years). More than 20.8% of 
eligible residents were older than 85 years. The most common predisposing fac-
tors were the faecal and/or urinary incontinence (43.9%), followed by impaired 
mobility (i.e., wheelchair bound or bedridden) (36.5%) and disorientation in time 
and/or space (29.9%). The occurrence of urinary catheter (1.4%), recent surgery 
(0.6%) and vascular catheter (0.1%) was very limited.
Infections
On the day of the survey, 252 residents were presented signs/symptoms 
of an infection. The prevalence of infections was 2.1% (IQR, 0–10.1%). Of all 
infection groups, infections of skin and soft tissues (36.5%) were the most fre-
quently presented on the day of the survey, followed by the infections of respira-
tory tract (28.6%) and urinary tract (21.8%). The group of skin and soft tissue 
infections primarily comprised of cellulitis, soft tissue or wound infections 
(80.4%). Scabies (13%), fungal infection (5.4%) and herpes simplex or zoster in-
fection (1.1%) were not common in these settings. The respiratory infection group 
mostly included common cold or pharyngitis (51.4%) and other lower respiratory 
tract infection (31.9%). Among urinary tract infections, non-indwelling-catheter-
related urinary tract infections were the most frequent (98.2%). Detailed infor-
mation of the distribution of infections among the eligible residents can be found 
in Table I.
Antimicrobial use
156 residents were received at least one antimicrobial agents. The preva-
lence of antimicrobial use was 1.3% (IQR, 0–6.4%). 96.8% of reported antimicro-
bials were given for treatment of an infection. The most common indication for 
therapeutic antimicrobial use was the treatment of respiratory tract infections 
(40.9%), urinary tract infections (36.4%) and skin and soft tissue infections 
(15.9%) (Table I). The most common therapeutic antimicrobial agent (97.5%) be-
longed to the ATC J01 class of ‘antibacterials for systemic use’. The most impor-
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tant J01 subclasses were J01M quinolone antibacterials (34.2%), J01C beta-lactam 
antibacterials (26%), J01F macrolides, lincosamides and streptogramins (12.4%), 
and J01D other beta-lactam antibacterials (10.9%) (Fig. 1).
The most commonly prescribed empirically treatments for respiratory 
tract infections were beta-lactam antibacterials (40.9%), followed by other beta-
lactam antibacterials (21.3%) and macrolides, lincosamides and streptogramins 
(14.8%). The most often empirically prescribed antibacterials for urinary tract 
infections were quinolone antibacterials (64%), followed by sulfonamides and 
trimethoprim (15.6%) and beta-lactam antibacterials (7.8%). The most frequent 
antibacterials prescribed for therapy of skin and soft tissue infections were beta-
lactam antibacterials (47.4%), followed by macrolides, lincosamides and strepto-
gramins (26.3%) and tetracyclines (10.5%).
Only 2.4% of antimicrobials were microbiologically documented treat-
ments. Three positive microbiology results were available for gastrointestinal 
Figure 1. Distribution of use of J01 antibacterials for systematic use in 91 long-term care facilities 
in Hungary, April–May 2013
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 infection (Clostridium diffi cile), two for urinary tract infection (Enterobacter 
cloacae, Escherichia coli) and one for other infection (Staphylococcus aureus). 
No resistant strains were found.
A total of 3.2% of all prescribed antimicrobial agents was used for pro-
phylactic purposes. Antimicrobials were prescribed for the prevention of uri-
nary tract infections (60%) and ear, nose, mouth infections (40%) (Table I).
84.4% of participating LTCFs had no antimicrobial stewardship ele-
ments. The most frequent components of antimicrobial policies in the LTCFs 
were ‘restrictive list of antimicrobial to be prescribed’ (18.9%), ‘use of written 
guidelines’ (7.8%) and ‘feedback to physicians on institutional antimicrobial con-
sumption’ (4.4%). In LTCFs which had a restrictive list of antimicrobials to be 
prescribed, 73.7% of these settings restricted only intravenously administered 
antimicrobials.
Predisposing factors
Among eligible residents with at least one infection and antimicrobial 
agent, 65.1% and 61.6% were female. The median age was 78 and 77 years. The 
most frequent predisposing factors were impaired mobility (68.5% and 63.5%), 
followed by incontinence (63.9% and 61.6%) and disorientation (42.4% and 
35.8%). The association of infections and antimicrobial use with demographics 
and predisposing factors can be found in Table II.
Discussion
In the last decade, several European countries set up initiatives to increase 
awareness for the problem of infections and antimicrobial use in their LTCFs. 
The aim of the HALT-2 project in the EU Member States was to collect aggre-
gated data on infections and use of antimicrobial agents among elderly residents 
in LTCFs. At the national level, this survey gave insight into the burden of infec-
tions and antimicrobial use in Hungarian LTCFs.
In Hungary 91 LTCFs participated in this survey. Residents of participating 
LTCFs were elderly (more than one-forth aged over 85 years) and presented a 
heavy care load (more than one-third of the eligible residents surveyed inconti-
nent, immobile or disoriented) for the staff. This results are similar to the fi nd-
ings from other participating European LTCFs where the mean of residents with 
over 85 years, incontinence, disorientation and impaired mobility (46.5%, 65.8%, 
54.9% and 52.6%) were also high [11].
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The collected data allowed for the estimation of the prevalence of infec-
tions and antimicrobial use. The prevalence of infection among residents in Hun-
garian participating LTCFs was 2.1%. The infection prevalence rate was lower 
than those found in other European countries: 2.8% and 7.3% in Dutch LTCFs, 
4.3% in German LTCFs, 6.4% in Irish LTCFs and 7.6% in Norwegian LTCFs 
[11, 14–18]. Lower infection prevalence results were probably due to the general 
diagnostic problems (e.g., change in mental and/or cognitive status of elders), 
the lack of microbiological and radiological diagnostic testing, and/or good qual-
ity of LTCF nursing care. In addition, this fi nding suggested the negative infl u-
ence of reporting behaviour, despite the similar methodology, and the positive 
infl uence of qualifi ed nursing staff, because they can detect the signs and symp-
toms of an infection correctly. In our survey, skin and soft tissues infections 
(36.5%) was the most frequent, followed by the infection of respiratory tract 
(28.6%) and urinary tract (21.8%). However, in contrast with other recent studies 
that found urinary tract infections to be the most frequent infection, following by 
respiratory tract infections and skin and soft tissues infections [11, 15, 19–20]. 
The lower frequency of urinary tract infections can be explained by the infre-
quent use of urinary catheter in Hungarian LTCFs.
The prevalence of antimicrobial use among participating LTCFs was 
 lower (1.3%) compared with results from other European surveys (2.4–15%) [3, 
11, 21–23]. National result showed that the prevalence of antimicrobial use was 
lower than the prevalence of infections, thus the overuse of antimicrobials is 
not common in participating LTCFs. Although prescription of quinolone antibac-
terials was frequent (34.2%) in LTCFs, which can lead the increased presence 
of infections caused by Clostridium diffi cile and other antimicrobial resistant 
pathogens [22–27]. This result is similar to several overseas studies that quinolo-
nes are the most frequently prescribed antibacterials in LTCFs [20–27]. Among 
eligible residents receiving antibacterial agent for treatment of an infection, only 
2.4% of prescriptions were based microbiologically results. In comparison with 
the results from Norwegian and Dutch surveys (5.8% and 6.6%), our culture sam-
pling rate was low, probably due to the fact that microbiological diagnostic tests 
were not commonly requested by the physicians in the elderly care in Hungary 
[14, 18]. Antibiotic stewardship resources were uncommon in these settings. 
 Local data on antimicrobial resistance profi les, antimicrobial committee, feed-
back to the physicians on institutional antimicrobial consumption, advice from 
a pharmacist were available in less than 16% of the participating LTCFs. Similar 
to other European LTCFs, regular education sessions of prescribers is an impor-
tant and urgent action for improvement in Hungarian LTCFs [11, 28].
Our survey had some limitations. Firstly, the representativeness of the 
 survey sample was poor, although there was not a required sample size. Repre-
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sentativeness was less than optimal because LTCFs participated on a voluntary 
basis (convenient sample). Thus, our results could be heavily biased as a result of 
the very low number of participating LTCFs. Secondary, our national prevalence 
rates result from aggregating prevalence in individual LTCFs; therefore, these 
data must be interpreted with caution. Thirdly, low sensitivity (false negative or 
underreporting) of infections could be a problem, which may be related to the 
diffi culty in confi rming the case defi nition of an infection if sign and symptoms 
were not well documented in the residents’ medical record or diagnoses of infec-
tion made were not always correct or because of this survey relied on self-ad-
ministered data. Finally, we were not able to analyse the epidemiology of micro-
organisms, owing to the small number of microbiological samples performed. 
Several of these limitations may be improved in future surveys by increasing the 
number of participating LTCFs, enhanced training of LTCF staff in case defi ni-
tions or reinforcing efforts to improve the quality of residents’ medical records.
Despite these limitations, the HALT-2 project was the largest point-preva-
lence survey performed to date which was a great opportunity to get a compre-
hensive epidemiological overview of infections and use of antimicrobial agents 
in Hungarian LTCFs.
Based on our results, while a fi rst important step has been made improv-
ing skills in surveillance of infections and antimicrobial use and raising aware-
ness in Hungarian LTCFs, extensive training on infection prevention and control 
to healthcare practitioners is needed. In addition, there is a need for 1) implement-
ing national guidelines (e.g., hand hygiene, antimicrobial stewardship); 2) devel-
oping infection prevention and control programme including recommendations 
on organisational and structural arrangements, therapeutic procedures, resource 
requirements, surveillance objectives and training; and 3) establishing infection 
surveillance system specifi c for LTCFs in order to prevent unnecessary suffering 
of elderly people. In addition, this survey identifi ed an important area for targeted 
improvement of antimicrobial use including: reducing the use of quinolone anti-
bacterials in order to prevent the spread of Clostridium diffi cile and other antimi-
crobial resistant microorganisms among residents of LTCFs. Complex (i.e., dia-
lectic and interactive) trainings, providing feedback to physicians about their 
prescribing patterns, and locally developed antimicrobial stewardship may im-
prove the quality of antibiotic prescribing [29–31]. For additional research, we 
consider it necessary to also take in consideration other factors (e.g., determina-
tion of risk factors for preventable infections, attribu table morbidity and mortal-
ity) in order to explore which efforts help to prevent infections. Furthermore, 
other detailed information on the cost of infections is needed to assist efforts at 
prioritizing the national health policies.
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